ESR1 and breast carcinoma: In this study, syringin (2) promoted proliferation in human breast cancer MCF-7 cells by regulating the estrogen receptor pathway, specifically ER-α and p-ERα expression, a mechanism similar to that of estrogen, 17β-estradiol.